Use of Dexmedetomidine in a Pediatric Heart Transplant Patient
Authors:
- 11 August 2005
- journal article
- case report
- Published by Springer Nature in Pediatric Cardiology
- Vol. 26 (5) , 651-654
Abstract
Dexmedetomidine is a new sedative and analgesic agent that has a unique property of lack of respiratory depression. We describe a pediatric case in which the use of dexmedetomidine enabled us to successfully extubate a 12-year-old heart transplant patient with acute pneumonia after several failed attempts with the use of more conventional sedation.Keywords
This publication has 23 references indexed in Scilit:
- Bispectral index-guided sedation with dexmedetomidine in intensive care: A prospective, randomized, double blind, placebo-controlled phase II study*Critical Care Medicine, 2002
- DexmedetomidineDrugs, 2000
- The Use of Continuous IV Sedation Is Associated With Prolongation of Mechanical VentilationChest, 1998
- The Effect of Dexmedetomidine on the Balance of Myocardial Energy Requirement and Oxygen Supply and DemandAnesthesia & Analgesia, 1996
- Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unitCritical Care Medicine, 1995
- Effects of Intravenous Dexmedetomidine in HumansAnesthesiology, 1992
- The Use of Sedative Agents in Critically Ill PatientsDrugs, 1992
- Isoflurane compared with midazolam for sedation in the intensive care unit.BMJ, 1989
- Medetomidine — a novel α2-adrenoceptor agonist: A review of its pharmacodynamic effectsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1989
- The techniques used to sedate ventilated patientsIntensive Care Medicine, 1981